HTT and Huntington disease: In addition to focusing on HTT palmitoylation, a potential risk factor controlling the S-palmitoylation of TRPC5 channels could modulate TRPC5 channel expression and activity, providing new insights into novel therapeutic strategies for HD (Hong et al., 2020).